Advancing Regenerative Medicine: The FetTech MTP® Innovation Pipeline

FetTech’s Multi-Tissue Platform (MTP®) has changed how patients heal - redefining what’s possible through regenerative medicine.

2018: The Breakthrough begins

XCelliStem® Wound Powder receives FDA-clearance, marking a major milestone in regenerative medicine. Now trusted in Trauma, Burn, Wound Care, and OR settings across the U.S.

2019: Antiviral Potential Discovered

Research reveals that MTP technology exhibits broad-spectrum activity against enveloped viruses - paving the way for VyraMed®.

2024: From Powder to Liquid ECM

ReyaGel the first and only liquid ECM, recieves FDA-clearance. Made from the same trusted MTP® Wound Powder, it expands possibilities for healing across medical and aesthetic applications.

 The Future of Healing

Exploring new delivery methods - including injection and inhalation - to advance recovery across injured, diseases, and viral conditions. Helping more patients heal — faster, safer, and more naturally.

Healing the future — one breakthrough at a time.

Scientist wearing a lab coat and safety goggles with a green background

  • While testing our FDA cleared product we discovered MTP kills enveloped viruses.

    New series of studies show MTP gel kills shingles, herpes, ebola, coronavirus and potentially all enveloped viruses 99.99% (within 1 minute).

    Human diseases caused by enveloped viruses include some of the most devastating and debilitating infections known to man, such as: covid, mononucleosis, pneumonia, Hodgkin's lymphoma, aseptic meningitis, Ebola, yellow fever, hemorrhagic fever, encephalitis, influenza, hepatitis, measles, mumps, rubella, smallpox, cowpox, monkeypox, HIV, rabies, chickenpox, and shingles. The government is currently working with MTP in anti-viral studies.

  • Skin rejuvenation

    Hair restoration

    Scar revision

  • Myocardial infarct injection

  • Nerve Regeneration

    Spinal Cord Injury

  • Osteoarthritis knee

    Spinal disc

    Tendon/ligament tear

  • Bladder wall thickening for incontinence

Any partners interested in collaboration, partnership, license, grant proposal please contact us at info@fettech.com

Our Revolutionary Technologies

  • VyraMed logo on a light background with abstract liquid texture. A FetTech company that uses MTP technology (aka Multi-Tissue Platform).

    VyraMed

    While testing our FDA cleared product, we discovered MTP kills enveloped viruses. Human diseases caused by enveloped viruses include some of the most devastating and debilitating infections known to man, such as: covid, hepatitis, smallpox, cowpox, monkeypox, HIV and shingles. The government is currently working with MTP in anti-viral studies.

    Discover The Technology
  • White powder with Stemsys logo on a plain background. A FetTech company that uses MTP technology (aka Multi-Tissue Platform).

    XCelliStem Wound Powder by StemSys

    The first FetTech medical device cleared by the FDA. XCelliStem Wound Powder has been used in hospitals throughout the US since 2018 and utilized for burns, trauma, chronic wounds and surgery. These products are safe and used to enhance healing.

    Discover The Technology
  • Reyagel brand logo on a white textured background with bubbles and a glossy finish.

    ReyaGel

    A breakthrough in skin recovery and tissue regeneration

    Set to transform skin rejuvenation treatments & enhance patient results forever.

    Discover The Technology
3D illustration of a human nervous system with glowing blue outlines, viewed from the back.

MTP Technology

When applied, it gives your body the tools and instructions needed to repair. Everyone’s body is unique and requires different instructions to heal. MTP gives your body what it specifically needs. MTP is naturally derived and safe.

Learn More